Mach F - Search Results

1

Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis.

Lenglet S, Quercioli A, Fabre M, Galan K, Pelli G, Nencioni A, Bauer I, Pende A, Python M, Bertolotto M, Spinella G, Pane B, Palombo D, Dallegri F, Mach F, Vuilleumier N, Montecucco F. Lenglet S, et al. Among authors: mach f. Mediators Inflamm. 2014;2014:720987. doi: 10.1155/2014/720987. Epub 2014 Feb 6. Mediators Inflamm. 2014. PMID: 24648660 Free PMC article.

2

The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells.

Kwak B, Mulhaupt F, Veillard N, Pelli G, Mach F. Kwak B, et al. Among authors: mach f. Swiss Med Wkly. 2001 Jan 27;131(3-4):41-6. doi: 10.4414/smw.2001.06144. Swiss Med Wkly. 2001. PMID: 11219190 Free article.

3

Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice.

Kwak BR, Veillard N, Pelli G, Mulhaupt F, James RW, Chanson M, Mach F. Kwak BR, et al. Among authors: mach f. Circulation. 2003 Feb 25;107(7):1033-9. doi: 10.1161/01.cir.0000051364.70064.d1. Circulation. 2003. PMID: 12600918

4

Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.

Mulhaupt F, Matter CM, Kwak BR, Pelli G, Veillard NR, Burger F, Graber P, Lüscher TF, Mach F. Mulhaupt F, et al. Among authors: mach f. Cardiovasc Res. 2003 Sep 1;59(3):755-66. doi: 10.1016/s0008-6363(03)00515-7. Cardiovasc Res. 2003. PMID: 14499877

5

Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice.

Veillard NR, Kwak B, Pelli G, Mulhaupt F, James RW, Proudfoot AE, Mach F. Veillard NR, et al. Among authors: mach f. Circ Res. 2004 Feb 6;94(2):253-61. doi: 10.1161/01.RES.0000109793.17591.4E. Epub 2003 Dec 1. Circ Res. 2004. PMID: 14656931

6

Dual benefit of reduced Cx43 on atherosclerosis in LDL receptor-deficient mice.

Wong CW, Burger F, Pelli G, Mach F, Kwak BR. Wong CW, et al. Among authors: mach f. Cell Commun Adhes. 2003 Jul-Dec;10(4-6):395-400. doi: 10.1080/cac.10.4-6.395.400. Cell Commun Adhes. 2003. PMID: 14681047 Free article.

7

Differential expression patterns of proinflammatory and antiinflammatory mediators during atherogenesis in mice.

Veillard NR, Steffens S, Burger F, Pelli G, Mach F. Veillard NR, et al. Among authors: mach f. Arterioscler Thromb Vasc Biol. 2004 Dec;24(12):2339-44. doi: 10.1161/01.ATV.0000146532.98235.e6. Epub 2004 Sep 30. Arterioscler Thromb Vasc Biol. 2004. PMID: 15458979

8

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

Steffens S, Veillard NR, Arnaud C, Pelli G, Burger F, Staub C, Karsak M, Zimmer A, Frossard JL, Mach F. Steffens S, et al. Among authors: mach f. Nature. 2005 Apr 7;434(7034):782-6. doi: 10.1038/nature03389. Nature. 2005. PMID: 15815632 Free article.

9

Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice.

Merhi-Soussi F, Kwak BR, Magne D, Chadjichristos C, Berti M, Pelli G, James RW, Mach F, Gabay C. Merhi-Soussi F, et al. Among authors: mach f. Cardiovasc Res. 2005 Jun 1;66(3):583-93. doi: 10.1016/j.cardiores.2005.01.008. Cardiovasc Res. 2005. PMID: 15914123

10

Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo.

Veillard NR, Steffens S, Pelli G, Lu B, Kwak BR, Gerard C, Charo IF, Mach F. Veillard NR, et al. Among authors: mach f. Circulation. 2005 Aug 9;112(6):870-8. doi: 10.1161/CIRCULATIONAHA.104.520718. Epub 2005 Aug 1. Circulation. 2005. PMID: 16061736

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

621 results

Search Page

Filters